Clinical Trials Directory

Trials / Completed

CompletedNCT04073992

Chronic Insomnia and CSF Markers of Dementia - Effects of Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
30 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The longstanding view has been that insomnia, and other forms of sleep disturbance, emerge as a consequence of dementia and are the result of progressive neuronal damage. However, there is growing evidence that the direction of causation may go both ways, with sleep disturbance potentially increasing vulnerability to dementia. Longitudinal studies have found that sleep disturbance often precedes and increases risk for dementia by several years. The purpose of this study is to examine whether treatment of insomnia with cognitive behavioral therapy (CBT-I) is associated with a decrease in dementia biomarkers found in cerebrospinal fluid (CSF). Fifteen adults age 30-50 with chronic insomnia will undergo overnight polysomnography and CSF sampling in the morning. This will be followed by 8 weeks of treatment with CBT-I and then repeat CSF sampling.

Conditions

Interventions

TypeNameDescription
BEHAVIORALcognitive behavioral treatment of insomniaA behavioral modification program consisting of 8 clinic sessions focused on sleep hygiene, stimulus control, sleep restriction, and cognitive restructuring.

Timeline

Start date
2019-09-01
Primary completion
2022-11-30
Completion
2022-12-30
First posted
2019-08-29
Last updated
2023-01-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04073992. Inclusion in this directory is not an endorsement.